Prostanoid Receptor EP2 as a Therapeutic Target

Journal of Medicinal Chemistry - United States
doi 10.1021/jm401431x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Chemical Society (ACS)

Related search

The EP2 Receptor Is the Predominant Prostanoid Receptor in the Human Ciliary Muscle.

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
1993English

Lysosomes as a Therapeutic Target

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2019English

CD38 as a Therapeutic Target

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
2006English

BMP Type II Receptor as a Therapeutic Target in Pulmonary Arterial Hypertension

Cellular and Molecular Life Sciences
Molecular NeuroscienceMolecular MedicineCell BiologyMolecular BiologyPharmacologyCellular
2017English

Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis

Frontiers in Pharmacology
Pharmacology
2017English

Prostanoid EP2 Receptors Are Up-Regulated in Human Pulmonary Arterial Hypertension: A Key Anti-Proliferative Target for Treprostinil in Smooth Muscle Cells

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2018English

Candida Albicansdimorphism as a Therapeutic Target

Expert Review of Anti-Infective Therapy
VirologyInfectious DiseasesMicrobiology
2012English

Tumor Evolution as a Therapeutic Target

Cancer Discovery
Oncology
2017English

GPR35 as a Novel Therapeutic Target

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy